
Opinion|Videos|December 23, 2024
Nonsurgical Treatments for Advanced BCC Management
Author(s)David Miller, MD, PhD, Kevin S. Emerick, MD
Panelists discuss how emerging nonsurgical options such as hedgehog pathway inhibitors, immune checkpoint inhibitors, and photodynamic therapy are expanding treatment possibilities for patients with advanced basal cell carcinoma (BCC), particularly for those unsuitable for or unresponsive to traditional surgical interventions.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
10 Skin Cancer Exam Tips
3
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
4
Dermatology Times Conferences & Meetings Calendar: September 2026
5





